These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 33599755)

  • 1. Response assessment during chemoradiation using a hypercellular/hyperperfused imaging phenotype predicts survival in patients with newly diagnosed glioblastoma.
    Kim MM; Aryal MP; Sun Y; Parmar HA; Li P; Schipper M; Wahl DR; Lawrence TS; Cao Y
    Neuro Oncol; 2021 Sep; 23(9):1537-1546. PubMed ID: 33599755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Phase 2 Study of Dose-intensified Chemoradiation Using Biologically Based Target Volume Definition in Patients With Newly Diagnosed Glioblastoma.
    Kim MM; Sun Y; Aryal MP; Parmar HA; Piert M; Rosen B; Mayo CS; Balter JM; Schipper M; Gabel N; Briceño EM; You D; Heth J; Al-Holou W; Umemura Y; Leung D; Junck L; Wahl DR; Lawrence TS; Cao Y
    Int J Radiat Oncol Biol Phys; 2021 Jul; 110(3):792-803. PubMed ID: 33524546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining Perfusion and High B-value Diffusion MRI to Inform Prognosis and Predict Failure Patterns in Glioblastoma.
    Wahl DR; Kim MM; Aryal MP; Hartman H; Lawrence TS; Schipper MJ; Parmar HA; Cao Y
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):757-764. PubMed ID: 29980414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing a Pipeline for Multiparametric MRI-Guided Radiation Therapy: Initial Results from a Phase II Clinical Trial in Newly Diagnosed Glioblastoma.
    Kim MM; Parmar HA; Aryal MP; Mayo CS; Balter JM; Lawrence TS; Cao Y
    Tomography; 2019 Mar; 5(1):118-126. PubMed ID: 30854449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypercellularity Components of Glioblastoma Identified by High b-Value Diffusion-Weighted Imaging.
    Pramanik PP; Parmar HA; Mammoser AG; Junck LR; Kim MM; Tsien CI; Lawrence TS; Cao Y
    Int J Radiat Oncol Biol Phys; 2015 Jul; 92(4):811-9. PubMed ID: 26104935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-chemoradiation volumetric response predicts survival in newly diagnosed glioblastoma treated with radiation, temozolomide, and bevacizumab or placebo.
    Ellingson BM; Abrey LE; Garcia J; Chinot O; Wick W; Saran F; Nishikawa R; Henriksson R; Mason WP; Harris RJ; Leu K; Woodworth DC; Mehta A; Raymond C; Chakhoyan A; Pope WB; Cloughesy TF
    Neuro Oncol; 2018 Oct; 20(11):1525-1535. PubMed ID: 29897562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can MRI-derived factors predict the survival in glioblastoma patients treated with postoperative chemoradiation therapy?
    Nakamura H; Murakami R; Hirai T; Kitajima M; Yamashita Y
    Acta Radiol; 2013 Mar; 54(2):214-20. PubMed ID: 23138021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mono-exponential, diffusion kurtosis and stretched exponential diffusion MR imaging response to chemoradiation in newly diagnosed glioblastoma.
    Chakhoyan A; Woodworth DC; Harris RJ; Lai A; Nghiemphu PL; Liau LM; Pope WB; Cloughesy TF; Ellingson BM
    J Neurooncol; 2018 Sep; 139(3):651-659. PubMed ID: 29855771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiparametric MR Imaging of Diffusion and Perfusion in Contrast-enhancing and Nonenhancing Components in Patients with Glioblastoma.
    Boonzaier NR; Larkin TJ; Matys T; van der Hoorn A; Yan JL; Price SJ
    Radiology; 2017 Jul; 284(1):180-190. PubMed ID: 28240563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between apparent diffusion coefficient and survival as a function of distance from gross tumor volume on radiation planning MRI in newly diagnosed glioblastoma.
    Jabehdar Maralani P; Stewart J; Hiremath S; Lawrence L; Chan R; Lau A; Chen H; Chan A; Zeng LK; Tseng CL; Myrehaug S; Soliman H; Detsky J; Heyn C; Lim Fat M; Lipsman N; Sahgal A
    J Neurooncol; 2023 Sep; 164(3):597-605. PubMed ID: 37707752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical parameters outweigh diffusion- and perfusion-derived MRI parameters in predicting survival in newly diagnosed glioblastoma.
    Burth S; Kickingereder P; Eidel O; Tichy D; Bonekamp D; Weberling L; Wick A; Löw S; Hertenstein A; Nowosielski M; Schlemmer HP; Wick W; Bendszus M; Radbruch A
    Neuro Oncol; 2016 Dec; 18(12):1673-1679. PubMed ID: 27298312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of MGMT promoter status in non-resectable glioblastoma after adjuvant therapy.
    Iaccarino C; Orlandi E; Ruggeri F; Nicoli D; Torricelli F; Maggi M; Cerasti D; Pisanello A; Pedrazzi G; Froio E; Crafa P; D'Abbiero N; Michiara M; Ghadirpour R; Servadei F
    Clin Neurol Neurosurg; 2015 May; 132():1-8. PubMed ID: 25723791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standard dose and dose-escalated radiation therapy are associated with favorable survival in select elderly patients with newly diagnosed glioblastoma.
    Jackson WC; Tsien CI; Junck L; Leung D; Hervey-Jumper S; Orringer D; Heth J; Wahl DR; Spratt DE; Cao Y; Lawrence TS; Kim MM
    J Neurooncol; 2018 May; 138(1):155-162. PubMed ID: 29388034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival analysis in patients with newly diagnosed primary glioblastoma multiforme using pre- and post-treatment peritumoral perfusion imaging parameters.
    Bag AK; Cezayirli PC; Davenport JJ; Gaddikeri S; Fathallah-Shaykh HM; Cantor A; Han XS; Nabors LB
    J Neurooncol; 2014 Nov; 120(2):361-70. PubMed ID: 25098699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of Progression-Free-Survival in Glioblastomas by Intratreatment Dynamic Contrast-Enhanced MRI.
    Bisdas S; Smrdel U; Bajrovic FF; Surlan-Popovic K
    Clin Neuroradiol; 2016 Mar; 26(1):39-45. PubMed ID: 25164691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amino-acid PET versus MRI guided re-irradiation in patients with recurrent glioblastoma multiforme (GLIAA) - protocol of a randomized phase II trial (NOA 10/ARO 2013-1).
    Oehlke O; Mix M; Graf E; Schimek-Jasch T; Nestle U; Götz I; Schneider-Fuchs S; Weyerbrock A; Mader I; Baumert BG; Short SC; Meyer PT; Weber WA; Grosu AL
    BMC Cancer; 2016 Oct; 16(1):769. PubMed ID: 27716184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival Prediction Analysis in Glioblastoma With Diffusion Kurtosis Imaging.
    Li Y; Kim MM; Wahl DR; Lawrence TS; Parmar H; Cao Y
    Front Oncol; 2021; 11():690036. PubMed ID: 34336676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do perfusion and diffusion MRI predict glioblastoma relapse sites following chemoradiation?
    Khalifa J; Tensaouti F; Lotterie JA; Catalaa I; Chaltiel L; Benouaich-Amiel A; Gomez-Roca C; Noël G; Truc G; Péran P; Berry I; Sunyach MP; Charissoux M; Johnson C; Cohen-Jonathan Moyal E; Laprie A
    J Neurooncol; 2016 Oct; 130(1):181-192. PubMed ID: 27502603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Voxel-based evidence of perfusion normalization in glioblastoma patients included in a phase I-II trial of radiotherapy/tipifarnib combination.
    Ken S; Deviers A; Filleron T; Catalaa I; Lotterie JA; Khalifa J; Lubrano V; Berry I; Péran P; Celsis P; Moyal EC; Laprie A
    J Neurooncol; 2015 Sep; 124(3):465-73. PubMed ID: 26189058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of care and outcomes of chemoradiation versus radiation alone for MGMT promoter unmethylated glioblastoma.
    Lee A; Malakhov N; Sheth N; Wang A; Han P; Schreiber D
    Clin Neurol Neurosurg; 2018 Jul; 170():127-131. PubMed ID: 29777945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.